SAM advises Omega Hospitals majority stake acquisition in Cytecare Hospitals

Hyderabad Institute of Oncology Private Limited, which operates the Omega Hospitals oncology network, has acquired a majority stake in Cytecare Hospitals Private Limited, a Bengaluru-based cancer care provider.

The acquisition provides for a complete exit by the founders and major shareholders of Cytcare Hospitals, namely, Broad Street Investments Holding (Singapore) Pte. Ltd (Goldman Sachs), Gi Global Health Fund LP and Alrox Enterprises Private Limited.

Shardul Amarchand Mangaldas & Co advised Hyderabad Institute of Oncology on this stake acquisition.

The transaction team was led by Nivedita Tiwari (Partner) along with Devesh Pandey (Partner), Kuhuk Jain (Principal Associate), Tweisha Mishra (Senior Associate) and Anushka Ganguli (Associate).

This acquisition marks Omega Hospitals’ entry into the Bengaluru oncology market and forms part of its broader national expansion strategy to strengthen its presence across India.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.